Skip to main content
Top
Published in: Reactions Weekly 1/2023

01-01-2023 | Acute Kidney Injury | Case report

AZD-1222

Relapsed focal segmental glomerulosclerosis and severe acute kidney injury: case report

Published in: Reactions Weekly | Issue 1/2023

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Huang Y-T, et al. Relapsed focal segmental glomerulosclerosis and severe acute kidney injury after Oxford-AstraZeneca (AZ) COVID-19 vaccine. Archives of Medical Science 18: 1693-1695, No. 6, et al. Nov 2022. Available from: URL: http://doi.org/10.5114/aoms/153477 Huang Y-T, et al. Relapsed focal segmental glomerulosclerosis and severe acute kidney injury after Oxford-AstraZeneca (AZ) COVID-19 vaccine. Archives of Medical Science 18: 1693-1695, No. 6, et al. Nov 2022. Available from: URL: http://​doi.​org/​10.​5114/​aoms/​153477
Metadata
Title
AZD-1222
Relapsed focal segmental glomerulosclerosis and severe acute kidney injury: case report
Publication date
01-01-2023
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-30431-2

Other articles of this Issue 1/2023

Reactions Weekly 1/2023 Go to the issue

Case report

Voriconazole

Case report

Oseltamivir

Case report

Rituximab